Trials / Completed
CompletedNCT04083859
Digital Outreach Intervention for Lung Cancer Screening
A Pragmatic Randomized-Controlled Trial of a Digital Outreach Intervention for Lung Cancer Screening: mPATH-Lung (Mobile Patient Technology for Health-Lung)
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 26,998 (actual)
- Sponsor
- Wake Forest University Health Sciences · Academic / Other
- Sex
- All
- Age
- 50 Years – 77 Years
- Healthy volunteers
- Accepted
Summary
mPATH-Lung (mobile Patient Technology for Health - Lung) is an innovative digital outreach program that identifies patients who qualify for lung cancer screening and helps them get screened. The study will: 1) Determine the effect of mPATH-Lung on receipt of lung cancer screening in a pragmatic randomized-controlled trial conducted with primary care patients in two large health networks, 2) Elucidate the drivers of patients' screening decisions and screening behavior; and 3) Explore implementation outcomes that will impact the sustainability and dissemination of mPATH-Lung using program data, surveys, and interviews. This project will determine how mPATH-Lung affects patients' screening decisions and their completion of screening.
Detailed description
Primary Objective: Determine the effectiveness of mPATH-Lung on receipt of LCS in a randomized pragmatic clinical trial of 1318 patients recruited from two large health networks, Wake Forest Baptist Health and the University of North Carolina at Chapel Hill. Secondary Objectives: * Elucidate the drivers of patients' decisions to receive or forgo LCS through a values clarification exercise embedded within mPATH-Lung and supplemental semi-structured interviews of at least 50 patients. * Assess several critical implementation outcomes (reach, acceptability, and appropriateness) to inform the sustainability and scalability of mPATH-Lung across diverse primary care settings
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | mPATH-Lung | A web-based program that determines patients eligibility for lung cancer screening (LCS), informs them of LCS, presents them with personalized risk-benefit information, helps them make a screening decision, and helps them schedule a LCS clinic appointment. |
| OTHER | Lung health video | Web-based video about guideline recommended exercise for lung health |
Timeline
- Start date
- 2022-01-01
- Primary completion
- 2023-09-30
- Completion
- 2024-09-30
- First posted
- 2019-09-10
- Last updated
- 2025-06-25
- Results posted
- 2025-01-16
Locations
2 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT04083859. Inclusion in this directory is not an endorsement.